Theoretical mechanisms by which hyperglycemia and insulin resistance could cause cardiovascular diseases in diabetes

Diabetes Care

Volumn 22, Issue SUPPL. 3, 1999, Pages

  King, George L ^a,b   Wakasaki, Hisao ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); ALPHA TOCOPHEROL; CYTOKINE; GLUCOSE; INSULIN;

ATHEROSCLEROSIS; BLOOD FLOW; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GLUCOSE TRANSPORT; HORMONE ACTION; HYPERGLYCEMIA; INSULIN RESISTANCE; METABOLIC DISORDER; SIGNAL TRANSDUCTION; TISSUE REACTION; VASCULARIZATION;

CARDIOVASCULAR DISEASES; DIABETIC ANGIOPATHIES; DIGLYCERIDES; ENZYME ACTIVATION; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; PROTEIN KINASE C; RISK FACTORS;

EID: 0032915383     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Kuwabara T, Cogan DG: Retinal vascular patterns VI: mural cells of the retinal capillaries. Arch Ophthalmol 69:492a-502a, 1963
3. Krowlewski AS, Warram JH, Rand LI, Kahn CR: Epidemiologic approach to etiology of type 1 diabetes mellitus and its complications. N Engl J Med 329:977-986, 1993
4. Brownlee M: Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46:223-234, 1995
5. King GL, Shiba T, Oliver J, Inoguchi T, Bursell S-E: Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. Annu Rev Med 45:179-188, 1994
6. Greene D, Lattimer SA, Sima AAF: Sorbitol, phosphoinositides and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316:599-606, 1987
7. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
8. Nishizuka Y: Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9:484-496, 1995
9. King GL, Ishii H, Koya D: Diabetic vascular dysfunctions: a model of excessive activation of protein kinase C. Kidney Int 52:S77-S85, 1997
10. Dereubertis FR, Craven PA: Activation of protein kinase C in glomerular cells in diabetes: mechanisms and potential link to the pathogenesis of diabetic glomerulopathy. Diabetes 43:1-8, 1994
11. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL: Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci U S A 89:11059-11062, 1992
12. Koya D, Jirousek MR, Lin Y-W, Ishii H, Kuboki K, King GL: Characteristics of protein kinase C β isoform activation on the gene expression of transforming growth factor β, extracellular matrix components and prostanoids in the glomeruli of diabetic rats. JCI 100:115-126, 1997
13. 2. J Clin Invest 96:733-740, 1995
14. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A 90:1814-1818, 1993
15. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530, 1996
16. Ziyadeh FK, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 93:536-542, 1994
17. Hostetter TH, Troy JL, Breener BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19:410-415, 1981
18. Anderson S, Jung FF, Ingelfinger JR: Renal renin-angiotensin system in diabetes: functional immunohistochemical and molecular biological correlations. Am J Physiol 265:F477-F486, 1993
19. Komers R, Allen TJ, Cooper ME: Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes 43:1190-1197, 1994
20. Tesfamariam B, Brown ML, Cohen RA: Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 87:1643-1648, 1991
21. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell S-E, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL: Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science 272:728-731, 1996
22. 77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers. J Cell Physiol 153:62-75, 1992
23. 1 overexpression augments phorbol ester-induced increase in endothelial permeability. J Cell Physiol 166:249-255, 1996
24. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluids of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487, 1994
25. Xia P, Aiello LP, Ishii H, Jiang Z, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, King GL: Characterization of vascular endothelial growth factors effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98:2018-2026, 1996
26. Williams B, Gallachen B, Patel H, Orme C: Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by vascular smooth muscle cells in vitro. Diabetes 46:1497-1503, 1997
27. Lewis EJ, Hunsicker LG, Bain RP, Rhode RD: The effect of angiotensin convening enzyme inhibitor on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
28. Kunisaki M, Bursell S-E, Umeda F, Nawata H, King GL: Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes 43:1372-1377, 1994
29. Kunisaki M, Bursell S-E, Clermont AC, Ishii H, Ballas LM, Jirousek MR, Umeda F, Nawata H, King GL: Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol 269:E239-E246, 1995
30. Tasinato A, Boscoboinik D, Bartoli GM, Maroni P, Azziz A: d-α-Tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition and is independent of its antioxidant properties. Proc Natl Acad Sci U S A 92:12190-12194, 1995
31. Koya D, Lee I-K, Ishii H, Kanoh H, King GL: Prevention of glomerular dysfunctions in diabetic rats by treatment of d-α-tocopherol. J Am Soc Nephrol 8:426-435, 1997
32. Raman M, Nesto RW: Heart disease in diabetes mellitus. Endocrinol Metab Clin North Am 25:425-438, 1996
33. Wakasaki H, Koya D, Schuen FJ, Jirousek MR, Ways DK, Hoit BD, Walsh RA, King GL: Targeted overexpression of protein kinase C isoform in myocardium causes cardiomyopathy. Proc Natl Acad U S A 94:9320-9325, 1997
34. Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957, 1996
35. Feener EP, King GL: Vascular dysfunction in diabetes mellitus. Lancet 350:S19-S113, 1997
36. Colwell JA, Lopes-Virella M, Halushka PV: Pathogenesis of atherosclerosis in diabetes mellitus. Diabetes Care 4:121-133, 1981
37. King GL, Davidheiser S, Banskota N, Oliver J, Inoguchi T: Insulin receptors and actions on vascular cells. In Nova Nordisk Foundation Symposium No. 5. Smith U, Bruun NE, Hedner T, Hokfelt B, Eds. Amsterdam, Excerpta Medica, 1991, p. 183-187
38. Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G, Baron AS: Obesity/insulin resistance is associated with endothelial dysfunction. J Clin Invest 97:2601-2610, 1996
39. Savage PJ, Saad MF: Insulin and atherosclerosis: villain, accomplice or innocent bystander? Br Heart J 69:473-475, 1993
40. Follo F, Kahn CR, Hansen H, Bouchie JL, Feener EP: Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels: a potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J Clin Invest 100:2158-2169, 1997
41. Bruning JC, Winnay J, Cheatham B, Kahn CR: Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells. Mol Cell Biol 17:1513-1521, 1997